CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the Eagle device for selective laser trabeculoplasty. Laser energy is delivered in a noncontact ...

Eyes that switched from eye drops to SLT had a significant reduction in the average number of medications. Eyes with uncontrolled IOP benefited from SLT, but some still needed trabeculectomy.

I’m writing to share about a recent eye procedure I had that is relevant to Ohio Senate Bill 36, the primary eye care modernization bill our policymakers are currently debating. I underwent a ...

With the ongoing pandemic, ophthalmologists continue to search for new ways to reduce patient visits and possible virus exposure without sacrificing outcomes. Not surprisingly, monitoring and ...

More than 70 million people worldwide suffer from glaucoma, a condition that causes a build-up of fluid and pressure inside the eye and can eventually lead to blindness. Treatment options have ...

More than 70 million people worldwide suffer from glaucoma. Treatment options have traditionally included eye drops to reduce the fluid the eye produces or surgery to unclog the eye's drainage. But a ...

Alcon has announced the US release of its Voyager direct selective laser trabeculoplasty (DSLT) platform, with a launch event scheduled for the American Glaucoma Society annual meeting later in ...